Protective mechanisms of IVIG

被引:52
作者
Clynes, Raphael [1 ,2 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA
关键词
D O I
10.1016/j.coi.2007.09.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IVIG therapeutic action likely includes several discrete mechanisms of action that kinetically may be distinct (Figure 2); blocking effects of phagocytic Fcγ receptors by IgG multimers would be immediate-acting and transient (hours), while FcRn blocking would lead to decreased autoantibody serum levels over several days. In contrast, the induction of regulatory monocytes/DCs might instead have sustained anti-inflammatory consequences on the chronic inflammatory response. In particular the inhibition of dendritic cell activation and dampening of the IFN-γ response would be expected to block both the adaptive T cell response and its pro-inflammatory consequences. The cellular and molecular details underlying the induction of the IVIG immunosuppressive program are likely to reveal new insights into our understanding of IgG immunobiology and provide new strategies for the design of more effective immunotherapeutics. © 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:646 / 651
页数:6
相关论文
共 59 条
[41]   Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis [J].
Lock, C ;
Hermans, G ;
Pedotti, R ;
Brendolan, A ;
Schadt, E ;
Garren, H ;
Langer-Gould, A ;
Strober, S ;
Cannella, B ;
Allard, J ;
Klonowski, P ;
Austin, A ;
Lad, N ;
Kaminski, N ;
Galli, SJ ;
Oksenberg, JR ;
Raine, CS ;
Heller, R ;
Steinman, L .
NATURE MEDICINE, 2002, 8 (05) :500-508
[42]   Divergent immunoglobulin G subclass activity through selective Fc receptor binding [J].
Nimmerjahn, F ;
Ravetch, JV .
SCIENCE, 2005, 310 (5753) :1510-1512
[43]   FcγRIII-dependent inhibition of interferon-γ responses mediates suppressive effects of intravenous immune globulin [J].
Park-Min, Kyung-Hyun ;
Serbina, Natalya V. ;
Yang, Wentian ;
Ma, Xiaojing ;
Krystal, Gerald ;
Neel, Benjamin G. ;
Nutt, Stephen L. ;
Hu, Xiaoyu ;
Ivashkiv, Lionel B. .
IMMUNITY, 2007, 26 (01) :67-78
[44]   Identification of FcαRI as an inhibitory receptor that controls inflammation:: Dual role of FcRγ ITAM [J].
Pasquier, B ;
Launay, P ;
Kanamaru, Y ;
Moura, IC ;
Pfirsch, S ;
Ruffié, C ;
Hénin, D ;
Benhamou, M ;
Pretolani, M ;
Blank, U ;
Monteiro, RC .
IMMUNITY, 2005, 22 (01) :31-42
[45]   Divergent roles for Fc receptors and complement in vivo [J].
Ravetch, JV ;
Clynes, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :421-432
[46]   Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor [J].
Samuelsson, A ;
Towers, TL ;
Ravetch, JV .
SCIENCE, 2001, 291 (5503) :484-486
[47]   Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients [J].
Scaradavou, A ;
Woo, B ;
Woloski, BMR ;
CunninghamRundles, S ;
Ettinger, LJ ;
Aledort, LM ;
Bussel, JB .
BLOOD, 1997, 89 (08) :2689-2700
[48]   Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity [J].
Shields, RL ;
Lai, J ;
Keck, R ;
O'Connell, LY ;
Hong, K ;
Meng, YG ;
Weikert, SHA ;
Presta, LG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (30) :26733-26740
[49]   Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus [J].
Shoenfeld, Y ;
Rauova, L ;
Gilburd, B ;
Kvapil, F ;
Goldberg, I ;
Kopolovic, J ;
Rovensky, J ;
Blank, M .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (11) :1303-1311
[50]   Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? [J].
Siragam, V ;
Brinc, D ;
Crow, AR ;
Song, S ;
Freedman, J ;
Lazarus, AH .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (01) :155-160